29.11.2018 • NewsBASFDede WillamsTDI

BASF Halts TDI Plant due to Shipping Woes

Shipping Woes Halts BASF’s TDI Plant due to Shipping Woes (c) BASF
Shipping Woes Halts BASF’s TDI Plant due to Shipping Woes (c) BASF

Due to low water levels on the Rhine River, BASF has been faced with restrictions on shipping, and this week was forced to shutter its mammoth TDI plant at Ludwigshafen due to a shortage of raw materials.

The German group, which said it would restart the plant when conditions permitted, has not declared force majeur on supplies from the 300,000 t/y facility, however.

Built at a cost of €1 billion, the Ludwigshafen plant – which is part of an integrated production complex – has been beset by numerous problems, even before its commissioning in November 2015. Construction was delayed initially by the find of a World War 2 legacy bomb at the site.

In 2016, major technical glitches led to delays in reaching full capacity for the polyurethane feedstock. After a long hiatus due to contamination of PU foam with dichlorobenzene, the facility was only re-started in the second half of October 2018.  At that time, a new reactor was installed.

With the ongoing drought leading to historically low water levels along Europe’s most important waterway, BASF and other chemical producers have had to move goods via pipeline, road and rail; this not been sufficient to take up the slack, however.

German engineering plastics producer Covestro recently revised its financial outlook for the year downward, citing drought-related problems in shipping.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read